Arbutus Biopharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $10,739 | $1,764 | $1,574 | $1,339 |
Gross Profit | 10,728 | -7,195 | 1,241 | 1,339 |
EBITDA | 2,562 | -24,165 | -12,169 | -19,352 |
EBIT | 2,551 | -24,498 | -12,502 | -19,688 |
Net Income | 2,523 | -24,526 | -12,532 | -19,717 |
Net Change In Cash | 10,739 | 1,764 | 1,574 | 1,339 |
Free Cash Flow | -15,749 | -13,391 | -10,401 | -20,736 |
Cash | 37,412 | 37,076 | 36,330 | 31,846 |
Basic Shares | 192,399 | 190,707 | 189,963 | 188,997 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,171 | $18,141 | $39,019 | $10,988 |
Gross Profit | 4,791 | -55,559 | 37,592 | 9,235 |
EBITDA | -68,403 | -70,986 | -61,859 | -71,637 |
EBIT | -69,783 | -72,390 | -63,286 | -73,390 |
Net Income | -69,920 | -72,849 | -69,456 | -77,351 |
Net Change In Cash | 6,171 | 18,141 | 39,019 | 10,988 |
Cost of Revenue | -78,484 | 57,026 | ||
Free Cash Flow | -65,032 | -86,944 | -35,868 | -68,341 |
Cash | 36,330 | 26,285 | 30,776 | 109,282 |
Basic Shares | 185,608 | 165,960 | 150,939 | 106,242 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.01 |
2025-03-31 | -$0.18 |
2024-12-31 | -$0.09 |
